Position in HIMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$437,786
New position
Shares Held
21,088
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026IHT Wealth Management, LLC holds $3,631,591 across 6 Drug Manufacturers - Specialty & Generic names. HIMS ranks #2 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | XERS |
Xeris Biopharma Holdings, Inc.
|
376,476 | $2,183,560 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
This page
|
21,088 | $437,786 | |
| 3 | VTRS |
Viatris Inc
|
25,819 | $348,814 | |
| 4 | HROW |
Harrow, Inc.
|
7,758 | $273,547 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,525 | $226,653 | |
| 6 | HLN |
Haleon plc
|
16,107 | $161,231 |
All Filings in HIMS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $437,786 | 21,088 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||